These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6349090)

  • 21. Retinoblastoma-like tumors induced by human adenovirus type 12 in rats.
    Kobayashi S; Mukai N
    Cancer Res; 1974 Jul; 34(7):1646-51. PubMed ID: 4600165
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterisation of ocular melanoma with cutaneous melanoma antibodies.
    Bomanji J; Garner A; Prasad J; Albert DM; Hungerford JL; Granowska M; Britton KE
    Br J Ophthalmol; 1987 Sep; 71(9):647-50. PubMed ID: 3311140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Melanoma of the uvea, cancer of the eye and immune phenomena].
    Vérin P; Gendre P; Meunier J
    Arch Ophtalmol Rev Gen Ophtalmol; 1972; 32():Suppl 1:21-8. PubMed ID: 4262497
    [No Abstract]   [Full Text] [Related]  

  • 24. [Retinal S-antigen and retinoblastoma--an immunohistochemical study].
    Song Y; Yao GD; Fu CC
    Zhonghua Yan Ke Za Zhi; 1994 Jan; 30(1):41-3. PubMed ID: 8082475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of HLA antigens in paraffin sections of uveal melanomas.
    Jager MJ; de Wolff-Rouendaal D; Breebaart AC; Ruiter DJ
    Doc Ophthalmol; 1986 Dec; 64(1):69-76. PubMed ID: 3556115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiretinoblastoma monoclonal antibodies.
    Char DH; Rand N; Howes EL; Lyon H; Morita CT
    Retina; 1983; 3(3):200-5. PubMed ID: 6356261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Distribution of the HLA antigen system in melanoblastoma of the uvea].
    Ignatov RK; Terent'eva LS; Shul'gina NS
    Oftalmol Zh; 1977; 32(4):289-94. PubMed ID: 896116
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of viruses in the pathogenesis of ocular tumors.
    Albert DM; Rabson AS
    Int Ophthalmol Clin; 1972; 12(1):195-224. PubMed ID: 4345548
    [No Abstract]   [Full Text] [Related]  

  • 29. Cell-mediated immunity to a retinoblastoma tissue culture line in patients with retinoblastoma.
    Char DH; Ellsworth R; Rabson AS; Albert DM; Herberman RB
    Am J Ophthalmol; 1974 Jul; 78(1):5-11. PubMed ID: 4835050
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunohistological characterisation of retinoblastoma and related ocular tissue.
    Tarlton JF; Easty DL
    Br J Ophthalmol; 1990 Mar; 74(3):144-9. PubMed ID: 2322511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
    Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
    Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicity of a monoclonal F(ab')2:ricin A conjugate for retinoblastoma in vitro.
    Merriam JC; Lyon HS; Char DH
    Cancer Res; 1984 Aug; 44(8):3178-83. PubMed ID: 6744258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunologic phenomenon and melanosarcoma of the uvea].
    Verin P; Meunier J; Gendre P; Bergeon JJ; Sekkat A; Morax S
    Arch Ophtalmol Rev Gen Ophtalmol; 1971 Nov; 31(11):781-92. PubMed ID: 4259656
    [No Abstract]   [Full Text] [Related]  

  • 34. Dead or alive: immunogenicity of human melanoma cells when presented by dendritic cells.
    Shaif-Muthana M; McIntyre C; Sisley K; Rennie I; Murray A
    Cancer Res; 2000 Nov; 60(22):6441-7. PubMed ID: 11103811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ocular autoimmunity and retinoblastoma].
    Bloch-Michel E; Faure JP; Belehradek J; Youn JK; Lexuan S; Campinchi R; Timsit JC
    Bull Soc Ophtalmol Fr; 1981 Dec; 81(12):1127-9. PubMed ID: 7343146
    [No Abstract]   [Full Text] [Related]  

  • 36. Cutaneous delayed hypersensitivity responses of patients with retinoblastoma to standard recall antigens and crude membrane extracts of retino-blastoma tissue culture cells.
    Char DH; Herberman RB
    Am J Ophthalmol; 1974 Jul; 78(1):40-4. PubMed ID: 4600659
    [No Abstract]   [Full Text] [Related]  

  • 37. CEA family syndrome. Abnormal carcinoembryonic antigen (CEA) levels in asymptomatic retinoblastoma family members.
    Felberg NT; Michelson JB; Shields JA
    Cancer; 1976 Mar; 37(3):1397-402. PubMed ID: 1260660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Various indicators of cellular and humoral immunity in children with retinoblastoma].
    Khvatova AV; Skriabina OA; Katargina LA; Murav'eva TV
    Vestn Oftalmol; 1988; 104(1):43-5. PubMed ID: 3369043
    [No Abstract]   [Full Text] [Related]  

  • 39. Assessment of immunological techniques in the diagnosis and prognosis of ocular malignant melanoma.
    Cochran AJ; Foulds WS; Damato BE; Trope GE; Morrison L; Lee WR
    Br J Ophthalmol; 1985 Mar; 69(3):171-6. PubMed ID: 3884037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characteristics of autoimmune process in melanoma of the uveal tract].
    Linnik LF; Chabrova LS; Zarobelova ON
    Ross Med Zh; 1992; (3):29-31. PubMed ID: 1643355
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.